| Literature DB >> 27012922 |
Eva Spada1, Ilaria Canzi2, Luciana Baggiani3, Roberta Perego4, Fabrizio Vitale5, Antonella Migliazzo6, Daniela Proverbio7.
Abstract
Stray cats in the city of Milan, Italy, were tested for Leishmania infantum and other selected infections. Twenty-seven cats (30.0%) were seroreactive by indirect fluorescent antibody test (IFAT), with an antibody titer of 1:40 for 16 (17.7%) cats and 1:80 (cut-off for feline L. infantum infection) for 11 (12.2%) cats. One blood (1.1%) and one popliteal lymph node (1.1%) sample tested positive by real-time polymerase chain reaction; no oculoconjunctival swabs tested positive. Feline immunodeficiency virus, feline leukemia virus, and feline coronavirus (FCoV) seroprevalence determined by enzyme-linked immunosorbent assay was 6.1, 6.1, and 39.0%, respectively. Toxoplasma gondii, Bartonella henselae, and Chlamydophila felis prevalence determined by IFAT was 29.3, 17.1, and 17.1%, respectively. The frequency of seroreactivity to L. infantum was significantly higher in FCoV-seropositive cats (OR=4.4, P=0.04). L. infantum-infected stray cats in Milan have a high seropositivity rate, comparable to that of cats in areas endemic for leishmaniosis.Entities:
Keywords: Bartonella henselae; Chlamydophila felis; FCoV; FIV; FeLV; Feline; Leishmania infantum; Real-time PCR; Seroprevalence; Toxoplasma gondii
Mesh:
Substances:
Year: 2016 PMID: 27012922 PMCID: PMC7132376 DOI: 10.1016/j.cimid.2016.03.001
Source DB: PubMed Journal: Comp Immunol Microbiol Infect Dis ISSN: 0147-9571 Impact factor: 2.268
Characteristics of a population of 90 stray cats in northern Italy examined for L. infantum infection, and comparison of seropositivity and seronegativity as determined by indirect fluorescent antibody test (IFAT).
| Factor | Category | Total population | IFAT for | ||
|---|---|---|---|---|---|
| Seropositive titer ≥ 1:80 | Seronegative titer < 1:80 | ||||
| Age | Young (<6 months) | 19 (21.1%) | 2 (10.5%) | 17 (89.5%) | >0.999 |
| Adult (>6 months) | 71 (78.9%) | 9 (12.7%) | 62 (87.3%) | ||
| Sex | Female | 54 (60.0%) | 5 (9.3%) | 49 (90.7%) | 0.34 |
| Male | 36 (40.0%) | 6 (16.7%) | 30 (83.3%) | ||
| BCS | Poor (<3/9) | 13 (14.5%) | 1 (7.7%) | 12 (92.3%) | >0.999 |
| Good (>4/9) | 77 (85.5%) | 10 (13%) | 67 (87.0%) | ||
| Colony of origin | Zone 1 | 11 (12.2%) | 1 (9.1%) | 10 (90.9%) | >0.999 |
| Zone 2 | 20 (22.2%) | 2 (10.0%) | 18 (90.0%) | >0.999 | |
| Zone 3 | 4 (4.4%) | 0 (0.0%) | 4 (100%) | >0.999 | |
| Zone 4 | 3 (3.3%) | 1 (33.3%) | 2 (67.7%) | 0.33 | |
| Zone 5 | 12 (13.3%) | 3 (25.0%) | 9 (75.0%) | 0.16 | |
| Zone 6 | 1 (1.1%) | 0 (0.0%) | 1 (100%) | >0.999 | |
| Zone 7 | 11 (12.2%) | 2 (18.2%) | 9 (81.8%) | 0.62 | |
| Zone 8 | 5 (5.5%) | 0 (0.0%) | 5 (100%) | >0.999 | |
| Zone 9 | 17(18.8%) | 2 (11.8%) | 15 (88.2%) | >0.999 | |
| Clinical examination | Healthy | 21 (23.3%) | 2 (9.5%) | 19 (90.5%) | >0.999 |
| Unhealthy | 69 (76.7%) | 9 (13%) | 60 (87.0%) | ||
| Stomatitis | 35 (38.9%) | 6 (17.1%) | 29 (82.9%) | 0.33 | |
| Ocular discharge | 4 (4.4%) | 0 (0.0%) | 4 (100%) | >0.999 | |
| Nasal discharge | 3 (3.3%) | 1 (33.3%) | 2 (66.7%) | 0.33 | |
| Pale mucous membranes | 5 (5.6%) | 1 (20.0%) | 4 (80.0%) | 0.49 | |
| Lymphadenomegaly | 65 (72.2%) | 9 (13.8%) | 56 (86.2%) | 0.72 | |
| Dermatologic examination | Absence of lesions | 59 (65.6%) | 9 (15.3%) | 50 (84.7%) | 0.33 |
| Presence of lesions | 31 (34.4%) | 2 (6.5%) | 29 (93.5%) | ||
| Crusting dermatitis | 11 (12.2%) | 0 (0.0%) | 11 (100%) | 0.35 | |
| Nodular dermatitis | 2 (2.2%) | 1 (50.0%) | 1 (50.0%) | 0.23 | |
| Alopecia | 2 (2.2%) | 0 (0.0%) | 2 (100%) | >0.999 | |
| Ectoparasites | 90 (100%) | 11 (12.2%) | 79 (87.8%) | NA | |
BCS = body condition score; NA = not applicable. P values < 0.05 are considered indicative of statistical significance.
Prevalence of FIV, FeLV, FCoV, Toxoplasma gondii, Bartonella henselae, and Chlamydophila felis infections in a population of 82 stray colony cats in Milan, northern Italy, and P values relative to their association with seropositivity by IFAT for Leishmania infantum at titers of 1:40 and 1:80.
| Pathogen (diagnostic method) | Prevalence (%; 95% CI) | |||||
|---|---|---|---|---|---|---|
| 1:40 | 1:80 (cut-off value) | |||||
| FIV (ELISA) | 5/82 (6.1; 1.6–11.7) | 1/25 | >0.999 | 0/10 (0.0%) | >0.999 | |
| FeLV (ELISA) | 5/82 (6.1; 1.6–11.7) | 2/25 | 0.64 | 2/10 (20.0%) | 0.11 | |
| FCoV (ELISA) | 32/82 (39.0; 21.9–45.2) | 12/25 | 0.39 | 7/10 (70.0%) | ||
| 1:32 | 26/82 (31.7; 17.0–38.1) | 7/25 | 0.83 | 3/10 (30.0%) | >0.999 | |
| 1:64 (cut-off value) | 24/82 (29.3; 15.4–35.7) | 7/25 | 0.92 | 3/10 (30.0%) | >0.999 | |
| 1:128 | 20/82 (24.4; 12.2–30.9) | 6/25 | 0.82 | 2/10 (20.0%) | >0.999 | |
| 1:32 | 23/82 (28.0; 14.6–34.5) | 8/25 | 0.80 | 3/10 (30.0%) | >0.999 | |
| 1:64 (cut-off value) | 14/82 (17.1; 7.7–23.5) | 6/25 | 0.43 | 2/10 (20.0%) | 0.68 | |
| 1:128 | 11/82 (13.4; 5.5–19.7) | 5/25 | 0.42 | 2/10 (20.0%) | 0.62 | |
| 1:20 | 21/82 (25.6; 13.0–32.1) | 10/25 | 0.09 | 4/10 (40.0%) | 0.27 | |
| 1:40 (cut-off value) | 14/82 (17.1; 7.7–23.5) | 7/25 | 0.16 | 3/10 (30.0%) | 0.36 | |
| 1:80 ( | 7/78 (9.0; 2.8–14.4) | 4/23 | 0.19 | 2/10 (20.0%) | 0.18 | |
FIV = feline immunodeficiency virus; FeLV = feline leukemia virus; FCoV = feline coronavirus; ELISA = enzyme-linked immunosorbent assay; IFAT = indirect fluorescent antibody test. Statistically significant results (P < 0.05) shown in bold.
Data from logistic regression analysis.
Co-infections involving Leishmania and other pathogens as determined by analysis of serum from 82 stray cats from the city of Milan, in northern Italy.
| Pathogen | No. of serum samples | Prevalence % (95% CI) |
| 0 | 0 (0.0–3.69) | |
| 2 | 2.4 (0.24–7.23) | |
| 7 | 8.5 (2.81–14.42) | |
| 3 | 3.7 (0.62–8.77) | |
| 2 | 2.4 (0.24–7.23) | |
| 3 | 3.7 (0.62–8.77) | |
| 2 | 2.4 (0.24–7.23) | |
| 1 | 1.2 (0.03–5.57) | |
| 1 | 1.2 (0.03–5.57) | |
| 2 | 2.4 (0.24–7.23) | |
| 1 | 1.2 (0.03–5.57) | |
| 1 | 1.2 (0.03–5.57) | |
| 1 | 1.2 (0.03–5.57) |
L. inf = Leishmania infantum, FIV = feline immunodeficiency virus; FeLV = feline leukemia virus; FCoV = feline coronavirus.